Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Other companies in Protagonist Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Celcuity Inc (NASDAQ:CELC), Cogent Biosciences Inc (NASDAQ:COGT), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Vaxcyte Inc (NASDAQ:PCVX).
Protagonist Therapeutics has a consensus price target of $93.44.
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $102.62 last updated April 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Protagonist Therapeutics.
Protagonist Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Protagonist Therapeutics.
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.